Application no. and date | 12721093.8 (espacenet) (Federated) (European Patent Register), 20120502 | Patent/reg. no. and date | DK/EP 2704798, 20170712 | Publication date | 20140312 | Priority no. and date | US 201161481533 P, 20110502, US 201161550545 P, 20111024, US 201261585859 P, 20120112 | EP pub. no. and date |
EP 2704798 20140312 | Effective date | | Applicant/owner | Takeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP | Applicant ref. no. | P62655DK01 | Inventor | DILUZIO, Willow, 7 Fernwood Drive
Westford Massachusetts 01886, US, TRUONG, Nobel T., 26 Stailbrook Road
Milford Massachusetts 01757, US, PALANIAPPAN, Vaithianathan, 7 Spruce Circle
Andover Massachusetts 01810, US, BROWN, Jason, 10 September Lane
Burlington Massachusetts 01803, US, FOX, Irving H., 111 Livingston Road
Wellesley Massachusetts 02482, US, SCHOLZ, Catherine, 1 Nashua Street
Woburn Massachusetts 01801, US, VARGA, Csanad M., 83 Commonwealth Park W
Newton, MA 02459, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | Opponent | | IPC Class | A61K 39/395 (2006.01) , A61P 1/00 (2006.01) , C07K 16/28 (2006.01) | Title | FORMULERING TIL ANTI-ALPHA4BETA7-ANTISTOF | Int. application no. | US2012036072 | Int. publication no. | WO2012151248 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|